According to Transgene SA's latest financial reports the company's current EPS (TTM) is -ยฃ1.82. In 2022 the company made an earnings per share (EPS) of -ยฃ0.27 a decrease over its 2021 EPS that were of -ยฃ0.18.
Year | EPS | Change |
---|---|---|
2022 | -ยฃ0.27 | 48.16% |
2021 | -ยฃ0.18 | -6.93% |
2020 | -ยฃ0.19 | -0.6% |
2019 | -ยฃ0.19 | -273.41% |
2018 | ยฃ0.11 | -124.48% |
2017 | -ยฃ0.46 | 31.82% |
2016 | -ยฃ0.35 | -63.87% |
2015 | -ยฃ0.96 | -14.59% |
2014 | -ยฃ1.13 | -17.15% |
2013 | -ยฃ1.36 | 2.99% |
2012 | -ยฃ1.32 | 0.3% |
2011 | -ยฃ1.32 | 8.93% |
2010 | -ยฃ1.21 | -7.32% |
2009 | -ยฃ1.30 | 56.96% |
2008 | -ยฃ0.83 | 176.84% |
2007 | -ยฃ0.30 | -77.81% |
2006 | -ยฃ1.35 | 2.64% |
2005 (TTM) | -ยฃ1.32 | -41.23% |
2004 | -ยฃ2.24 | 18.71% |
2003 | -ยฃ1.89 | 35.08% |
2002 | -ยฃ1.40 | -16.55% |
2001 | -ยฃ1.68 | -37.1% |
2000 | -ยฃ2.67 | 13.45% |
1999 | -ยฃ2.35 | -60.26% |
1998 | -ยฃ5.91 | 109.21% |
1997 | -ยฃ2.83 |